The San Francisco Giants want to get into the basketball business

5 Comments

The San Francisco Giants may join the bidding for the NBA’s Golden State Warriors. The California iteration of the franchise is 48 years-old, so it makes sense that the organization that employs Brian Sabean would be interested. Heck, if the deal goes through he’s likely to play the entire basketball team at second base and have it bat leadoff.

The real reason for the potential investment: there’s talk of an arena near AT&T Park which the Giants could develop and operate, luring the team across the Bay from Oakland to San Francisco. At the same time, the team would like to realize financial synergies via its partial ownership of the regional sports network that broadcasts Warriors games.

Which kind of puts the whole Oakland A’s-San Jose thing in perspective.  The Giants have the money to literally buy other sports franchises, build arenas, become landlords and exploit the property via favorable broadcasting deals. Meanwhile, they’re threatening legal action and demanding tribute from Major League Baseball due to the mere possibility that the Athletics — one of the rinky-dinkiest operations in professional sports — might set up shop 50 miles to the south of them.

Hard to have any sympathy for them, really.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
0 Comments

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.